Financing type: non-brokered private placement
Gross proceeds: $2,479,226.58
Offering: 2,338,893 listed shares with 2,338,886 warrants
Offering price: $1.06 per listed share
Warrant exercise terms: $1.50 per listed share for a two-year period for Series A warrants and $2 per listed share for a three-year period for Series B warrants, subject to an acceleration right
Commissions in securities: 33,424 finders' warrants
Commission terms: Each non-transferable warrant is exercisable at $1.06 for a two-year period and entitles the holder to acquire one common share and one underlying warrant. Half of the underlying warrants are exercisable into one common share at $1.50 per listed share for a two-year period and another half at $2 per listed share for a three-year period.
Disclosure: Refer to the company's news releases dated Oct. 1, 2025, Oct. 20, 2025, and Oct. 22, 2025.
© 2026 Canjex Publishing Ltd. All rights reserved.